Cyclins and Breast Cancer

Overview

Journal J Mammary Gland Biol Neoplasia

Date 2004 Apr 15

PMID 15082921

Citations 90

Authors

Robert L Sutherland

Elizabeth A Musgrove

Affiliations

Soon will be listed here.

Abstract

The D-type and E-type cyclins control the G(1) to S phase transition during normal cell cycle progression and are critical components of steroid- and growth factor-induced mitogenesis in breast epithelial cells. Mammary epithelial cell-specific overexpression of these genes leads to mammary carcinoma, while in cyclin D1-deficient mice mammary gland development is arrested prior to lobuloalveolar development. Cyclin D1 null mice are resistant to mammary carcinoma induced by the neu and ras oncogenes, indicating an essential role for cyclin D1 in the development of some mammary cancers. Cyclin D1 and E1 are commonly overexpressed in primary breast cancer, with some evidence of an association with an adverse patient outcome. This observation may result in part from their ability to confer resistance to endocrine therapies. The functional consequences of cyclin E overexpression in breast cancer are likely related to its role in cell cycle progression, whereas that of cyclin D1 may also be a consequence of a more recently defined role in transcriptional regulation.

Citing Articles

Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms.

Zasheva D, Mladenov P, Zapryanova S, Gospodinova Z, Georgieva M, Alexandar I Molecules. 2024; 29(22).

PMID: 39598664 PMC: 11596968. DOI: 10.3390/molecules29225275.

Unraveling the anti-breast cancer activity of Cimicifugae rhizoma using biological network pathways and molecular dynamics simulation.

Sinha P, Yadav A Mol Divers. 2024; 29(1):241-254.

PMID: 38615110 DOI: 10.1007/s11030-024-10847-3.

Usefulness of machine learning and deep learning approaches in screening and early detection of breast cancer.

Ghorbian M, Ghorbian S Heliyon. 2023; 9(12):e22427.

PMID: 38076050 PMC: 10709063. DOI: 10.1016/j.heliyon.2023.e22427.

Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer.

Rommasi F Sci Rep. 2023; 13(1):8447.

PMID: 37231064 PMC: 10212935. DOI: 10.1038/s41598-023-35318-x.

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer.

Kinnel B, Singh S, Oprea-Ilies G, Singh R Cancers (Basel). 2023; 15(4).

PMID: 36831661 PMC: 9954028. DOI: 10.3390/cancers15041320.

References

Venditti M, Iwasiow B, Orr F, Shiu R . C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Int J Cancer. 2002; 99(1):35-42. DOI: 10.1002/ijc.10269. View

Ciemerych M, Kenney A, Sicinska E, Kalaszczynska I, Bronson R, Rowitch D . Development of mice expressing a single D-type cyclin. Genes Dev. 2002; 16(24):3277-89. PMC: 187507. DOI: 10.1101/gad.1023602. View

Dyson N . The regulation of E2F by pRB-family proteins. Genes Dev. 1998; 12(15):2245-62. DOI: 10.1101/gad.12.15.2245. View

Keyomarsi K, OLeary N, Molnar G, Lees E, Fingert H, Pardee A . Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 1994; 54(2):380-5. View

Zahnow C, Younes P, Laucirica R, Rosen J . Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst. 1997; 89(24):1887-91. DOI: 10.1093/jnci/89.24.1887. View

Tong W, Pollard J . Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice. Mol Cell Biol. 2001; 21(4):1319-28. PMC: 99584. DOI: 10.1128/MCB.21.4.1319-1328.2001. View

Ormandy C, Musgrove E, Hui R, Daly R, Sutherland R . Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat. 2003; 78(3):323-35. DOI: 10.1023/a:1023033708204. View

Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C . Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 1994; 54(7):1812-7. View

Sutherland R, Hall R, TAYLOR I . Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 1983; 43(9):3998-4006. View

10.

Seshadri R, Lee C, Hui R, McCaul K, Horsfall D, Sutherland R . Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res. 1996; 2(7):1177-84. View

11.

Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R . A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer. 1996; 73(6):728-34. PMC: 2074376. DOI: 10.1038/bjc.1996.128. View

12.

Foster J, Wimalasena J . Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol. 1996; 10(5):488-98. DOI: 10.1210/mend.10.5.8732680. View

13.

Cariou S, Donovan J, Flanagan W, Milic A, Bhattacharya N, Slingerland J . Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci U S A. 2000; 97(16):9042-6. PMC: 16818. DOI: 10.1073/pnas.160016897. View

14.

Musgrove E, Lee C, Buckley M, Sutherland R . Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci U S A. 1994; 91(17):8022-6. PMC: 44537. DOI: 10.1073/pnas.91.17.8022. View

15.

Musgrove E, Hunter L, Lee C, Swarbrick A, Hui R, Sutherland R . Cyclin D1 overexpression induces progestin resistance in T-47D breast cancer cells despite p27(Kip1) association with cyclin E-Cdk2. J Biol Chem. 2001; 276(50):47675-83. DOI: 10.1074/jbc.M106371200. View

16.

Lukas J, Bartkova J, Welcker M, Petersen O, Peters G, Strauss M . Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene. 1995; 10(11):2125-34. View

17.

Geng Y, Yu Q, Sicinska E, Das M, Bronson R, Sicinski P . Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. Proc Natl Acad Sci U S A. 2001; 98(1):194-9. PMC: 14567. DOI: 10.1073/pnas.98.1.194. View

18.

Altucci L, Addeo R, Cicatiello L, Dauvois S, Parker M, Truss M . 17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene. 1996; 12(11):2315-24. View

19.

Sweeney K, Swarbrick A, Sutherland R, Musgrove E . Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Oncogene. 1998; 16(22):2865-78. DOI: 10.1038/sj.onc.1201814. View

20.

Berns E, Foekens J, van Staveren I, van Putten W, de Koning H, Portengen H . Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment. Gene. 1995; 159(1):11-8. DOI: 10.1016/0378-1119(94)00534-y. View